[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367669-105":59,"doc-detail-367669-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","correlation-between-pathological-and-mri-radiological-tumor-responses-to-neoadjuvant-chemotherapy-in-non-luminal-breast-cancer-a-single-institution-experience","Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non-Luminal Breast Cancer: A Single Institution Experience","","Neoadjuvant chemotherapy (NACT) serves as standard treatment for locally advanced breast cancer and is increasingly used for early-stage triple-negative and HER2+ disease. The study evaluates the proposed correlation between post-NACT breast radiological and pathological tumor responses in non-luminal patients, and assesses MRI’s predictive value for treatment response. Using retrospective cases from December 2019 to November 2023, MRI accuracy is compared with pathological assessment, highlighting radiologist agreement and diagnostic performance metrics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correlation-between-pathological-and-mri-radiological-tumor-responses-to-neoadjuvant-chemotherapy-in-non-luminal-breast-cancer-a-single-institution-experience/367669/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correlation-between-pathological-and-mri-radiological-tumor-responses-to-neoadjuvant-chemotherapy-in-non-luminal-breast-cancer-a-single-institution-experience/367669.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical correlation does the study investigate after neoadjuvant chemotherapy?","Question",{"text":112,"@type":113},"The study investigates the correlation between breast radiological response on MRI and pathological tumor response after NACT in non-luminal breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is MRI performance for detecting tumor response reported?",{"text":117,"@type":113},"MRI sensitivity, specificity, and accuracy are reported as 86.4%, 96.8%, and 92.4%, with statistically significant findings (p-value mentioned).",{"name":119,"@type":110,"acceptedAnswer":120},"Does the study assess agreement between radiologists interpreting MRI?",{"text":121,"@type":113},"Yes. Radiological response between two radiologists shows good agreement, reported with a Kappa value of 0.801 and accompanying performance metrics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367669,1790232390,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nCorrelation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non-Luminal Breast Cancer: A Single Institution Experience  \nWesal M. Eldehna1,2  | Fawzy Elbarbry3  | Abdul Hameed Hassan4  | Rafat Abu Shakra5  | Ahmed Elaryan6  | Ola Mousa Abdelfattah Elnady1  | Elshaimaa Mohamed Mohamed6,7   \n1Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt | 2Department of Oncology, International Medical Center, Jeddah, Saudi Arabia | 3School of Pharmacy, Pacific University, Hillsboro, Oregon, USA | 4Department of Family Medicine, International Medical Center, Jeddah, Saudi Arabia | 5Department of Pathology and Laboratory Medicine, International Medical Center, Jeddah, Saudi Arabia | 6Department of Medical Imaging, International Medical Center, Jeddah, Saudi Arabia | 7Department of Diagnostic Radiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt  \nCorrespondence: Wesal M. Eldehna ([dr.wesalmoh@yahoo.com](dr.wesalmoh@yahoo.com))  \nReceived: 18 October 2024 | Revised: 24 June 2025 | Accepted: 27 June 2025  \nFunding: The authors received no specific funding for this work.  \nKeywords: breast cancer | correlation | magnetic resonance imaging | neoadjuvant chemotherapy | tumor response  \nABSTRACT  \nBackground: Neoadjuvant chemotherapy (NACT) is the standard treatment for patients with locally advanced breast cancer. In recent years, it has also been used for early-stage triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2-positive (HER2+) breast cancers.  \nObjectives: Our hypothesis asserts a correlation between breast radiological and pathological response post-NACT in nonluminal breast cancer patients. We also aimed to determine the predictive value of MRI in predicting response in these patients. Radiologist agreement upon radiological MRI response is also highlighted in the current study.  \nMethods: A retrospective study to evaluate MRI's accuracy for assessing tumor response to NACT in early and locally advanced non-metastatic breast cancer patients in comparison with pathological assessments. We enrolled cases that were treated with neoadjuvant chemotherapy between December 2019 and November 2023.  \nResults: Dynamic MRI's sensitivity to detect tumor response is 86.4%, its specificity is 96.8%, and its accuracy is 92.4%, with a significant p-value. So, the high correlation between measurements of residual disease detected by MRI and those detected by pathological assessment supports the use of MRI for imaging assessment during NACT. The two radiologists involved in our study were in good agreement in their assessment of radiological response (Kappa: 0.801, sensitivity: 85.7%, specificity: 93.8%, and accuracy: 90.6%) .  \nConclusions: The accuracy of imaging assessment by breast MRI during NACT is validated by the greater correlation between measurements of residual disease on MRI and pathology, establishing its role as the most precise imaging modality. We strongly advocate for the dependable role of MRI in monitoring breast lesions during neoadjuvant therapy, especially in non-luminal breast cancer cases, regardless of whether they present as mass or non-mass enhancement patterns.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2025; 8:e70275 1 of 13  \n[https://doi.org/10.1002/cnr2.70275](https://doi.org/10.1002/cnr2.70275)  \n1 | Introduction  \nBreast cancer is a major global health issue, with around 2.3 million new cases reported in 2020, making it the most common cancer globally. This highlights the urgent need for ongoing research, early detection, and effective treatment options. As awareness and screeni","cbCaiiahQbKb72Hv","https://ap.wps.com/l/cbCaiiahQbKb72Hv","pdf",918130,13,"English","# Introduction\n# Methods\n## Study design and participants\n## Imaging and pathological assessment\n# Results\n## MRI diagnostic performance\n## Radiologist agreement\n# Discussion\n# Conclusions","[{\"question\":\"What clinical correlation does the study investigate after neoadjuvant chemotherapy?\",\"answer\":\"The study investigates the correlation between breast radiological response on MRI and pathological tumor response after NACT in non-luminal breast cancer patients.\"},{\"question\":\"How is MRI performance for detecting tumor response reported?\",\"answer\":\"MRI sensitivity, specificity, and accuracy are reported as 86.4%, 96.8%, and 92.4%, with statistically significant findings (p-value mentioned).\"},{\"question\":\"Does the study assess agreement between radiologists interpreting MRI?\",\"answer\":\"Yes. Radiological response between two radiologists shows good agreement, reported with a Kappa value of 0.801 and accompanying performance metrics.\"}]","Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non-Luminal Breast Cancer: A Single Institution Experience | PDF",1790171902,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6af9d36b62cfe5eaffb48d6fef65de9b.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16d6030c4861f406fc50d19d460d377a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ce7a94ff5bcbe50c6512ac8552d57a9.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35a9f3b011d18023cc6fb33d11cade21.webp",980,1287]